UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 145

Sortiert nach

Infliximab (IFX) in Moderate to Severe Ulcerative Colitis (UC): Comparison between Scheduled Treatment Strategy and Bridge Strategy

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S402-S402

2017

Link zum Volltext

Verfügbarkeit prüfen

Sa1901 Rates of Colectomy in Ulcerative Colitis (UC) Through Time in a Latin-American Unit of IBD

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S397-S397

2016

Link zum Volltext

Verfügbarkeit prüfen

Tu1296 P-Glycoprotein 170 (P-GP) Functional Activity in Peripheral Blood Lymphocytes (PBL) According Clinical Response in IBD Patients Treated With Anti-TNFs

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-851-S-851

2015

Link zum Volltext

Verfügbarkeit prüfen

The Role of KATP Channels on Propofol Preconditioning in a Cellular Model of Renal Ischemia-Reperfusion

Anesthesia and analgesia, 2009-11, Vol.109 (5), p.1486-1492

2009

Link zum Volltext

Verfügbarkeit prüfen

Mo1713 The Role of the Galectin-1 in the Pathogenesis of IBD

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-642-S-642

2014

Link zum Volltext

Verfügbarkeit prüfen

Sa1930 Predictive Factors for Colectomy in Severe Corticosteroid (CS) Refractory Ulcerative Colitis (UC) Treated With Infliximab (IFX)

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-362-S-362

2012

Link zum Volltext

Verfügbarkeit prüfen

Infliximab (IFX) as Rescue Therapy in Acute Corticosteroid Resistant Ulcerative Colitis (UC)

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-590-S-590

2011

Link zum Volltext

Verfügbarkeit prüfen

Hydrochlorothiazide Potentiates Contractile Activity of Mouse Cavernosal Smooth Muscle

Sexual medicine, 2016-06, Vol.4 (2), p.e115-e125

2016

Link zum Volltext

Verfügbarkeit prüfen

W1292 Steroid-Dependent UC. Colectomy Risk at 5 Years Follow-up With Thiopurine Therapy

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-692-S-692

2010

Link zum Volltext

Verfügbarkeit prüfen

W1229 P-Glycoprotein (P-GP) Functional Activity in Peripheral Blood Lymphocytes (PBL) and Colonic Biopsies of Ulcerative Colitis (UC)

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-679-S-679

2010

Link zum Volltext

Verfügbarkeit prüfen

W1211 P-Glycoprotein 170 (P-GP) Functional Activity in Peripheral Blood Lymphocytes (Pbl) According Therapeutic Response in Ulcerative Colitis (UC)

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-679-A-679

2009

Link zum Volltext

Verfügbarkeit prüfen

T1178 Influence of Primary Sclerosing Cholangitis (PSC) On Ulcerative Colitis (UC) Disease Activity

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-501-A-501

2008

Link zum Volltext

Verfügbarkeit prüfen

Involvement of the Gi/o/cGMP/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1-7)

Biochemical journal, 2006-04, Vol.395 (1), p.183-190

2006

Link zum Volltext

Verfügbarkeit prüfen

Volcanic ash-driven worsening of mucosal inflammation in an experimental colitis model

Environmental pollution (1987), 2022-01, Vol.292, p.118351-118351, Article 118351

2022

Link zum Volltext

Verfügbarkeit prüfen

Mo1825 – Fecal Calprotectin (FCAL) Monitoring in Asymptomatic IBD Patients, Calculating the Optimal Cut-Off for Mucosal Healing in Our Population

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-851-S-852

2019

Link zum Volltext

Verfügbarkeit prüfen

Sa1944 - Infliximab (IFX) in Moderate to Severe Ulcerative Colitis (UC): Comparison between Scheduled Treatment Strategy and Bridge Strategy

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S402-S402

2017

Link zum Volltext

Verfügbarkeit prüfen

Tu1815 - Levels of the Circulating Anticoagulant and Anti-inflammatory Protein S (PROS1) in Patients with Inflammatory Bowel Disease (IBD)-Relationship with Disease Activity, IBD Patterns and C4-Binding Protein (C4Bp)

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-1027-S-1027

2018

Link zum Volltext

Verfügbarkeit prüfen

Su1959 - Decreased Levels of Circulatig Protein S in Patients with Active Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S612-S612

2017

Link zum Volltext

Verfügbarkeit prüfen

Characterization of [Ca2+]i Responses in Primary Cultures of Mouse Cardiomyocytes Induced by Trypanosoma cruzi Trypomastigotes

Memórias do Instituto Oswaldo Cruz, 2003-06, Vol.98 (4), p.487-493

2003

Link zum Volltext

Verfügbarkeit prüfen

Interstitial Lung Disease in a Patient Treated with Denosumab

European journal of case reports in internal medicine, 2019, Vol.6 (7), p.001131-001131

2019

Link zum Volltext

Verfügbarkeit prüfen

Effects of Angiotensin, vasopressin and aldosterone on proliferation of mcf-7 cells and their sensitivity to Doxorubicin

Anticancer research, 2014-04, Vol.34 (4), p.1843-1848

2014

Link zum Volltext

Verfügbarkeit prüfen

Modulation of ABCC1 and ABCG2 proteins by ouabain in human breast cancer cells

Anticancer research, 2014-03, Vol.34 (3), p.1441-1448

2014

Link zum Volltext

Verfügbarkeit prüfen

Assessment of pharmacokinetic interaction between piracetam and l-carnitine in healthy subjects

Biomedical chromatography, 2016-04, Vol.30 (4), p.536-542

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and pharmacodynamic evaluation of a nanotechnological topical formulation of lidocaine/prilocaine (nanorap) in healthy volunteers

Therapeutic drug monitoring, 2015-06, Vol.37 (3), p.362

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Infliximab (IFX) in Moderate to Severe Ulcerative Colitis (UC): Comparison between Scheduled Treatment Strategy and Bridge Strategy

Sa1901 Rates of Colectomy in Ulcerative Colitis (UC) Through Time in a Latin-American Unit of IBD

Tu1296 P-Glycoprotein 170 (P-GP) Functional Activity in Peripheral Blood Lymphocytes (PBL) According Clinical Response in IBD Patients Treated With Anti-TNFs

The Role of KATP Channels on Propofol Preconditioning in a Cellular Model of Renal Ischemia-Reperfusion

Mo1713 The Role of the Galectin-1 in the Pathogenesis of IBD

Sa1930 Predictive Factors for Colectomy in Severe Corticosteroid (CS) Refractory Ulcerative Colitis (UC) Treated With Infliximab (IFX)

Infliximab (IFX) as Rescue Therapy in Acute Corticosteroid Resistant Ulcerative Colitis (UC)

Hydrochlorothiazide Potentiates Contractile Activity of Mouse Cavernosal Smooth Muscle

W1292 Steroid-Dependent UC. Colectomy Risk at 5 Years Follow-up With Thiopurine Therapy

W1229 P-Glycoprotein (P-GP) Functional Activity in Peripheral Blood Lymphocytes (PBL) and Colonic Biopsies of Ulcerative Colitis (UC)

W1211 P-Glycoprotein 170 (P-GP) Functional Activity in Peripheral Blood Lymphocytes (Pbl) According Therapeutic Response in Ulcerative Colitis (UC)

Control of intestinal inflammation by glycosylation-dependent lectin-driven immunoregulatory circuits

T1178 Influence of Primary Sclerosing Cholangitis (PSC) On Ulcerative Colitis (UC) Disease Activity

Involvement of the Gi/o/cGMP/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1-7)

Volcanic ash-driven worsening of mucosal inflammation in an experimental colitis model

Mo1825 – Fecal Calprotectin (FCAL) Monitoring in Asymptomatic IBD Patients, Calculating the Optimal Cut-Off for Mucosal Healing in Our Population

Sa1944 - Infliximab (IFX) in Moderate to Severe Ulcerative Colitis (UC): Comparison between Scheduled Treatment Strategy and Bridge Strategy

Tu1815 - Levels of the Circulating Anticoagulant and Anti-inflammatory Protein S (PROS1) in Patients with Inflammatory Bowel Disease (IBD)-Relationship with Disease Activity, IBD Patterns and C4-Binding Protein (C4Bp)

Su1959 - Decreased Levels of Circulatig Protein S in Patients with Active Crohn’s Disease

Characterization of [Ca2+]i Responses in Primary Cultures of Mouse Cardiomyocytes Induced by Trypanosoma cruzi Trypomastigotes

Interstitial Lung Disease in a Patient Treated with Denosumab

Effects of Angiotensin, vasopressin and aldosterone on proliferation of mcf-7 cells and their sensitivity to Doxorubicin

Modulation of ABCC1 and ABCG2 proteins by ouabain in human breast cancer cells

Assessment of pharmacokinetic interaction between piracetam and l-carnitine in healthy subjects

Pharmacokinetic and pharmacodynamic evaluation of a nanotechnological topical formulation of lidocaine/prilocaine (nanorap) in healthy volunteers

Suchergebnisse filtern